VXRT Vaxart Inc

Aviragen Therapeutics Inc is a bio-pharmaceutical company. It is engaged in developing direct-acting antivirals to treat infections that affect a number of patients. It includes oral, small molecule compounds to treat infectious diseases.

$6.34  -0.35 (-5.23%)
As of 12/03/2021 15:59:54 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/19/2013
Outstanding shares:  125,496,066
Average volume:  3,971,444
Market cap:   $839,568,682
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92243A200
ISIN:        US92243A2006
Sedol:      BYWJD92
Valuation   (See tab for details)
PE ratio:   -12.48
PB ratio:   3.86
PS ratio:   715.14
Return on equity:   -31.02%
Net income %:   -5,414.57%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy